Prevention Pharmaceuticals Inc

Axcentria Pharmaceutical is a Telford, PA-based company specializing in the development and manufacturing of pharmaceutical products. With a focus on quality and innovation, Axcentria aims to improve patient outcomes through advanced therapeutic solutions. The company is committed to adhering to the highest regulatory standards, ensuring that all products meet rigorous quality benchmarks. By leveraging cutting-edge technology and expertise, Axcentria Pharmaceutical seeks to address the evolving needs of the healthcare industry. Generated from the website

Dermpathe Pharmaceuticals is a research-driven company based in Washington, NJ, specializing in the development of innovative dermatological products. With a focus on cutting-edge technology and scientific expertise, the company is dedicated to improving skin health and addressing various dermatological conditions. Dermpathe Pharmaceuticals conducts rigorous research and clinical trials to bring safe and effective skincare solutions to market. Committed to advancing the field of dermatology, the company strives to provide high-quality products that meet the needs of healthcare professionals and patients alike. Generated from their business information

Prolong Pharmaceuticals, LLC, based in South Plainfield, NJ, is a clinical-stage biopharmaceutical company dedicated to developing innovative treatments for complex diseases, including ischemia, hypoxia within stroke, sickle cell disease, and cystic fibrosis. With a leadership team experienced in biotechnology and a pioneering approach to PEGylation, Prolong aims to meet critical unmet medical needs through its cutting-edge biopharma solutions. The company's flagship product, PP-007 Sanguinate, employs a novel PEGylated technology to restore homeostasis by delivering oxygen to hypoxic tissues and facilitating improved perfusion while reducing inflammation. Prolong Pharmaceuticals is committed to advancing healthcare through groundbreaking therapies targeting severe and life-threatening conditions, with a strong focus on addressing the global health issue of stroke. Generated from the website